STOCK TITAN

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

Integra LifeSciences (NASDAQ: IART) will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to market open.

(Neutral)
(Neutral)
Tags
conferences earnings date

Integra LifeSciences (NASDAQ: IART) will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to market open. Management will host a conference call at 8:30 a.m. ET with a live webcast on the company Investor site.

Investors can register to receive dial-in details and a PIN; joining 10 minutes early is recommended. A webcast replay will be posted on the Investors section following the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Feb 9 session
-2.93% close to close Open Argus
Details

News Market Reaction – IART

In the Feb 9 session, IART declined 2.93%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines the timing of Integra’s fourth quarter and full-year 2025 earnings releas...
Analysis

This announcement outlines the timing of Integra’s fourth quarter and full-year 2025 earnings release and conference call on February 26, 2026 at 8:30 a.m. ET. Similar conferences/earnings notices over the past year have produced only modest price moves, with an average reaction near -1.79%. Investors tracking the story may focus on the forthcoming details on revenue, profitability, and guidance, comparing them to prior quarterly trends and any recent strategic or regulatory developments.

Key Figures

Earnings call date: February 26, 2026 Call time: 8:30 a.m. ET
Earnings call date
February 26, 2026
Scheduled release of Q4 and full year 2025 results
Call time
8:30 a.m. ET
Scheduled start time for earnings conference call

Previous Conferences,earnings Reports

5 past events · Latest: 2025-10-15
Same Type 5 events
  1. 2025-10-15

    Earnings call scheduling

    24h Move
    -1.2%

    Announcement of Q3 2025 results release and earnings call timing.

  2. 2025-07-14

    Earnings call scheduling

    24h Move
    -3.9%

    Scheduling notice for Q2 2025 results and investor conference call.

  3. 2025-04-18

    Earnings call scheduling

    24h Move
    -4.0%

    Announcement of Q1 2025 results date and related conference call.

  4. 2025-02-04

    Earnings call scheduling

    24h Move
    +0.2%

    Notice of Q4 and full-year 2024 results release and call timing.

  5. 2024-10-14

    Earnings call scheduling

    24h Move
    -0.1%

    Scheduling of Q3 2024 financial results announcement and webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Integra LifeSciences

Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard products and solutions is trusted by healthcare professionals to improve patient outcomes. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com

Integra LifeSciences Holdings Corporation


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Integra LifeSciences (IART) report Q4 and full year 2025 results?

Integra will report Q4 and full year 2025 results on February 26, 2026 prior to market open. According to the company, the release precedes a management conference call scheduled for 8:30 a.m. ET the same day.

What time is the Integra (IART) earnings conference call on February 26, 2026?

The conference call is scheduled for 8:30 a.m. ET on February 26, 2026. According to the company, management will discuss fourth quarter and full year 2025 results and host a live webcast on the Investor site.

How can investors access the Integra (IART) earnings webcast and replay?

Investors can access a live webcast and replay on the company's Investor website at investor.integralife.com. According to the company, the webcast will be available live during the call and replayed on the Investors section afterward.

Do I need to register to join the Integra (IART) earnings call on February 26, 2026?

Registration is recommended to receive dial-in details and an individual PIN but is not mandatory. According to the company, registrants receive call instructions and joining 10 minutes early is suggested for a timely connection.

Will Integra (IART) provide a replay of the February 26, 2026 earnings call?

Yes, a webcast replay will be posted after the call on the company's Investor website. According to the company, the replay will be available in the Investors section following the conference call for later review.

Keep reading